Physician profile
Loren E Gomes
NPI 1972277622
$1,577.60
in general payments reported to CMS, 2019-2025
18 companies · $665 in 2025
The $665 reported for 2025 was more than what 80% of Primary Care providers received nationally (typical 2025 total: $170).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1.90 · 2022: $333 · 2023: $331 · 2024: $247 · 2025: $665.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,243.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,242.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $233.34 | 2022 | |
| Globus Medical, INC. | $223.90 | 2025 | Senza |
| Janssen Pharmaceuticals, INC | $195.61 | 2023 | Spravato, Xarelto |
| Novo Nordisk INC | $194.58 | 2023-2025 | Ozempic |
| Bayer Healthcare Pharmaceuticals INC. | $120.85 | 2025 | |
| Nevro Corp. | $115.40 | 2024 | Senza |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $96.89 | 2024 | Lifevest |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $89.87 | 2025 | Relistor |
| Protega Pharmaceutials INC | $84.63 | 2025 | Roxybond |
| Scilex Pharmaceuticals INC. | $54.29 | 2022-2023 | Ztlido |
| Hikma Pharmaceuticals USA | $36.34 | 2022 | |
| Grt US Holding, INC. | $27.42 | 2022 | |
| Collegium Pharmaceutical, INC. | $24.81 | 2023 | Xtampza |
| Averitas Pharma INC. | $21.89 | 2023 | Qutenza |
| Medtronic, INC. | $21.07 | 2025 | Inceptiv |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Curonix LLC | $18.91 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Valinor Pharma, LLC | $15.90 | 2024 | Movantik |
| Genentech USA, INC. | $1.90 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Loren Gomes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.